Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
apply liberally 15 minutes before sun exposure reapply at least every 2 hours use water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in sun, especially from 1...
protect this product from excessive heat and direct sun
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Avobenzone 3.0% | Sunscreen |
| Homosalate 15.0% | Sunscreen |
| Octisalate 5.0% | Sunscreen |
| Octocrylene 2.6% | Sunscreen |
| Oxybenzone 6.0% | Sunscreen |
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Water, glycerin, niacinamide, polymethylsilsesquioxane, polyethylene, pentylene glycol, palmitoyl pentapeptide-4, palmitoyl dipeptide-7, carnosine, panthenol, tocopheryl acetate, allantoin, camellia sinensis leaf extract, dimethicone, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, benzyl alcohol, titanium dioxide, stearyl alcohol, behenyl alcohol, PEG-100 stearate, cetyl alcohol, methylparaben, polyacrylamide, propylparaben, ethylparaben, cetearyl glucoside, cetearyl alcohol, C13-14 isoparaffin, dimethiconol, sodium ascorbyl phosphate, citric acid, BHT, disodium EDTA, laureth-7, stearic acid, palmitic acid, iodopropynyl butylcarbamate.
1-800-285-5170
Dist. by PROCTER & GAMBLE,
CINCINNATI, OH 45202
PRO X by OLAY ®
DERMATOLOGICAL ANTI-AGING
AGE REPAIR LOTION WITH
SUNSCREEN BROAD SPECTRUM
SPF 30
75 mL (2.5 FL OZ)
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 3 | |
| Homosalate | ACTIVE INGREDIENT | V06SV4M95S | 3 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 3 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 3 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 3 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 3 | |
| Homosalate | ACTIVE MOIETY | V06SV4M95S | 3 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 3 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 3 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 3 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 3 | |
| allantoin | INACTIVE INGREDIENT | 344S277G0Z | 3 | |
| ascorbic acid | INACTIVE INGREDIENT | PQ6CK8PD0R | 3 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 3 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 3 | |
| C13-14 isoparaffin | INACTIVE INGREDIENT | E4F12ROE70 | 3 | |
| carnosine | INACTIVE INGREDIENT | 8HO6PVN24W | 3 | |
| cetearyl glucoside | INACTIVE INGREDIENT | 09FUA47KNA | 3 | |
| cetostearyl alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 3 | |
| cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 3 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 3 | |
| decyl glucoside | INACTIVE INGREDIENT | Z17H97EA6Y | 3 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 3 | |
| docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 3 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 3 | |
| ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 3 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| green tea leaf | INACTIVE INGREDIENT | W2ZU1RY8B0 | 3 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 3 | |
| iodopropynyl butylcarbamate | INACTIVE INGREDIENT | 603P14DHEB | 3 | |
| isohexadecane | INACTIVE INGREDIENT | 918X1OUF1E | 3 | |
| lactic acid | INACTIVE INGREDIENT | 33X04XA5AT | 3 | |
| laureth-7 | INACTIVE INGREDIENT | Z95S6G8201 | 3 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 3 | |
| niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 3 | |
| palmitoyl lysylthreonine | INACTIVE INGREDIENT | JHF843U5C5 | 3 | |
| palmitoyl pentapeptide-4 | INACTIVE INGREDIENT | KK181SM5JG | 3 | |
| panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 3 | |
| PEG-100 stearate | INACTIVE INGREDIENT | YD01N1999R | 3 | |
| PEG-4 dilaurate | INACTIVE INGREDIENT | KCR71CW036 | 3 | |
| PEG-4 laurate | INACTIVE INGREDIENT | AYF4VM3N1Z | 3 | |
| pentylene glycol | INACTIVE INGREDIENT | 50C1307PZG | 3 | |
| polyethylene glycol 200 | INACTIVE INGREDIENT | R95B8J264J | 3 | |
| polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 3 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 3 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 3 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 37000-232 | 37000-232-75, 37000-232-30 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | JELLY / TOPICAL | 180 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET / ORAL | 50 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | GEL / VAGINAL | 2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRAMUSCULAR | 1000 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / INTRAMUSCULAR | 0.02 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| lactic acid | LACTIC ACID | 33X04XA5AT | INJECTION / INTRAMUSCULAR | 1.16 %w/v | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / SUBCUTANEOUS | 0.95 %w/v | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | SOLUTION / TOPICAL | 0.04 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | 6 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | SOLUTION / RESPIRATORY (INHALATION) | 0.04 %w/w | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CREAM / TOPICAL | 54.5 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| lactic acid | LACTIC ACID | 33X04XA5AT | CAPSULE / ORAL | 132 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | TABLET, ORALLY DISINTEGRATING / ORAL | 2.35 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1440 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | INJECTION / INTRACAVITARY | 5 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | 45 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | FILM, SOLUBLE / ORAL | 0.06 mg | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | LOTION / TOPICAL | 1000 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / INTRAVENOUS | 45 mg | ||
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / VAGINAL | 0.03 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | LOTION / TOPICAL | 1140 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | FILM, EXTENDED RELEASE / TRANSDERMAL | 85 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, SOLUTION / INFILTRATION | 0.2 %w/v | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | 3 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CAPSULE, EXTENDED RELEASE / ORAL | 1.23 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | TABLET, FILM COATED / ORAL | 20 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SPRAY / NASAL | 5 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| ascorbic acid | ASCORBIC ACID | PQ6CK8PD0R | POWDER, FOR SOLUTION / ORAL | 560 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / TOPICAL | 3 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| polyethylene glycol 200 | POLYETHYLENE GLYCOL 200 | R95B8J264J | CAPSULE / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a94fb431-7796-7d80-e053-2995a90a5ba2 | 4272eba8-6c26-448d-b71f-315cc212a83e | 2020-06-30 | Warnings | a94fb431-7796-7d80-e053-2995a90a5ba2 4272eba8-6c26-448d-b71f-315cc212a83e |
Adverse event summaries are temporarily unavailable. Other product information remains available.